Triple therapy with Lactobacilli acidophili, estriol plus pelvic floor rehabilitation for symptoms of urogenital aging in postmenopausal women

Archives of Gynecology and Obstetrics

Volumn 289, Issue 3, 2014, Pages 601-608

  Capobianco, Giampiero ^a   Wenger, Jean Marie ^b   Meloni, Giovanni Battista ^a   Dessole, Margherita ^a   Cherchi, Pier Luigi ^a   Dessole, Salvatore ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b Gynecologic and Obstetric Clinic   (Switzerland)

Author keywords

Lactobacillus acidophili; Pelvic floor rehabilitation; Postmenopausal women; Recurrent urinary tract infections; Urinary incontinence; Urogenital atrophy; Vaginal estriol

Indexed keywords

ESTRIOL; PROBIOTIC AGENT;

ADULT; AGING; ARTICLE; CLINICAL EFFECTIVENESS; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; FEMALE; HUMAN; LACTOBACILLI ACIDOPHILI; LACTOBACILLUS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PELVIC FLOOR MUSCLE TRAINING; POSTMENOPAUSE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; STRESS INCONTINENCE; URETHRA PRESSURE; URETHROCYSTOMETRY; URINARY TRACT INFECTION; URINE CULTURE; UROGENITAL ATROPHY; UROGENITAL TRACT DISEASE;

ADMINISTRATION, INTRAVAGINAL; AGED; AGING; ATROPHY; COMBINED MODALITY THERAPY; ELECTRIC STIMULATION THERAPY; ESTRIOL; EXERCISE THERAPY; FEMALE; HUMANS; LACTOBACILLUS; MIDDLE AGED; PELVIC FLOOR; POSTMENOPAUSE; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME; URINARY INCONTINENCE, STRESS; URINARY TRACT INFECTIONS; UROGENITAL SYSTEM;

EID: 84896708720     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-3030-6     Document Type: Article

References (39)

1. Singh S, van Herwijnen I, Phillips C (2013) The management of lower urogenital changes in the menopause. Menopause Int 19:77-81
2. Cardozo L, Bachmann G, McClish D, Fonda D, Birgenson L (1998) Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee. Obstet Gynecol 92:722-727
3. Legendre G, Ringa V, Fauconnier A, Fritel X (2013) Menopause, hormone treatment and urinary incontinence at midlife. Maturitas 74:26-30
4. Iosif CS, Batra S, Ek A, Astedt B (1981) Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 141:817-820
5. Smith P (1993) Estrogens and the urogenital tract. Acta Obstet Gynecol Scand 157(suppl):1-25
6. Cadieux PA, Burton J, Devillard E, Reid G (2009) Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 60(Suppl 6):13-18
7. Atassi F, Servin AL (2010) Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii NCC933 and vaginal strain Lactobacillus gasseri KS120.1 against enteric, uropathogenic and vaginosis-associated pathogens. FEMS Microbiol Lett 304:29-38
8. Antonio MA, Hillier SL (2003) DNA fingerprinting of Lactobacillus crispatus strain CTV-05 by repetitive element sequence-based PCR analysis in a pilot study of vaginal colonization. J Clin Microbiol 41:1881-1887
9. Raz R (2011) Urinary tract infection in postmenopausal women. Korean J Urol 52:801-808
10. Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, Yarova-Yarovaia Y, Fiedler T, Cox M, Stamm WE (2011) Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis 52:1212-1217
11. Samsioe G, Jansson I, Mellstrom D, Svanborg A (1985) Occurrence, nature and treatment of urinary incontinence in a 70-year-old female population. Maturitas 7:335-342
12. Nilsson K, Heimer G (1992) Low-dose oestradiol in the treatment of urogenital oestrogen deficiency: a pharmacokinetic and pharmacodynamic study. Maturitas 15:121-127
13. Smith P, Heimer G, Lindskog M, Ulmsten U (1993) Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 16:145-154
14. Fantl JA, Cardozo L, McClish DK (1994) Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the hormones and urogenital therapy committee. Obstet Gynecol 83:12-18
15. Dessole S, Rubattu G, Ambrosini G, Gallo O, Capobianco G, Cherchi PL, Marci R, Cosmi E (2004) Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Menopause 11:49-56
16. Esposito G (1991) Estriol: a weak estrogen or a different hormone? Gynecol Endocrinol 5:131-153
17. Heimer GM, Englund DE (1992) Effects of vaginally-administered oestriol on post-menopausal urogenital disorders: a cytohormonal study. Maturitas 14:171-179
18. Iosif CS (1992) Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women. Arch Gynecol Obstet 251:115-120
19. Foidart JM, Vervliet J, Buytaert P (1991) Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints. Maturitas 13:99-107
20. Van der Linden MC, Gerretsen G, Brandhorst MS, Ooms EC, Kremer CM, Doesburg WH (1993) The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito - urinary symptoms. Eur J Obstet Gynecol Reprod Biol 51:29-33
21. Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I (1994) A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol 171:624-632
22. Bottiglione F, Volpe A, Esposito G, De Aloysio D (1995) Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses. Maturitas 22:227-232
23. Barentsen R, van de Weijer PH, Schram JH (1997) Continuous low-dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Eur J Obstet Gynecol Reprod Biol 71:73-80
24. Dugal R, Hesla K, Sordal T, Aase KH, Lilleeidet O, Wickstrom E (2000) Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy. Acta Obstet Gynecol Scand 79:293-297
25. Kanne B, Jenny J (1991) Local administration of low-dose estriol and vital Lactobacillus acidophilus in postmenopause. Gynakol Rundsch 31:7-13
26. Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 329:753-756
27. Capobianco G, Donolo E, Borghero G, Dessole F, Cherchi Pl, Dessole S (2012) Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Arch Gynecol Obstet 285:397-403
28. Dmochowski RR, Miklos JR, Norton PA, Zinner NR, Yalcin I, Bump RC (2004) Duloxetine urinary incontinence study group. Duloxetine versus placebo for the treatment of Noth American women with stress urinary incontinence. J Urol 170:1259-1263
29. Berghmans LCM, Hendrikis HJM, Bo K, Hay-Smith EJ, de Bies RA, van Waalwijk, van Doorn ESC (1998) Conservative treatment of stress urinary incontinence in women: a systematic review of randomized clinical trials. Br J Urol 82:181-189
30. Castro RA, Arruda RM, Zanetti MRD, Santos PD, Sartori MGF, Girao MJBC (2008) Single-blind, randomized, controlled trial of pelvic floor muscle training, electrical stimulation, vaginal cones, and no active treatment in the management of stress urinary incontinence. Clinics 63:465-472
31. Leriche B, Conquy S (2010) Guidelines for rehabilitation management of non-neurological urinary incontinence in women. Prog Urol 20:S104-S108
32. Archer DF (2010) Efficacy and tolerability of local estrogen therapy for urogenital atrophy. Menopause 17:194-203
33. Ishiko O, Hirai K, Sumi T, Tatsuta I, Ogita S (2001) Hormone replacement therapy plus pelvic floor muscle exercise for postmenopausal stress incontinence. A randomized, controlled trial. J Reprod Med 46:213-220
34. Schar G, Kochli OR, Fritz M, Heller U (1995) Effect of vaginal estrogen therapy on urinary incontinence in postmenopause. Zentralbl Gynakol 117:77-80
35. Lose G, Englev E (2000) Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG 107:1029-1034
36. Bhatia NN, Bergman A, Karram MM (1989) Effects of estrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 160:176-181
37. Hilton P, Stanton SL (1983) The use of intravaginal estrogen cream in genuine stress incontinence. Br J Obstet Gynaecol 90:940-944
38. Sturdee DW, Panay N (2010) International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13:509-522
39. Jaisamrarn U, Triratanachat S, Chaikittisilpa S, Grob P, Prasauskas V, Taechakraichana N (2013) Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Climacteric 16:347-355